Pluri (PLUR) Share-based Compensation (2010 - 2025)
Pluri (PLUR) reported Share-based Compensation of $857000.0 for Q4 2025, up 234.77% year-over-year from $256000.0 in Q4 2024, and down 36.52% quarter-over-quarter from $1.3 million in Q3 2025.
Pluri (PLUR) Share-based Compensation (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Share-based Compensation data on file, last reported at $857000.0 in Q4 2025.
- Share-based Compensation for Q4 2025 came in at $857000.0, up 234.77% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.4 million (up 122.9% YoY), and the FY2025 annual result was $2.1 million, down 18.14% from the prior year.
- Share-based Compensation slipped to $857000.0 in Q4 2025 per PLUR's latest filing, from $1.3 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $8.7 million in Q2 2022 and troughed at $38000.0 in Q3 2022.
- A 5-year average of $1.4 million and a median of $574500.0 in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2021 and 2022: Share-based Compensation soared 7709.52% in 2021, then slumped 98.83% in 2022.
- A 5-year view of Share-based Compensation shows it stood at $69000.0 in 2021, then decreased by 20.29% to $55000.0 in 2022, then soared by 461.82% to $309000.0 in 2023, then declined by 17.15% to $256000.0 in 2024, then soared by 234.77% to $857000.0 in 2025.
- Business Quant data shows PLUR's Share-based Compensation at $857000.0 in Q4 2025, $1.3 million in Q3 2025, and $838000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 26.47 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 857,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 857,000.00 |
| Dec 31, 2025 | 857,000.00 |
| Sep 30, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 838,000.00 |
| Jun 30, 2025 | 838,000.00 |
| Mar 31, 2025 | 332,000.00 |
| Mar 31, 2025 | 332,000.00 |
| Dec 31, 2024 | 256,000.00 |
| Dec 31, 2024 | 256,000.00 |
| Sep 30, 2024 | 558,000.00 |
| Sep 30, 2024 | 558,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Mar 31, 2024 | 110,000.00 |
| Mar 31, 2024 | 110,000.00 |
| Dec 31, 2023 | 309,000.00 |
| Dec 31, 2023 | 309,000.00 |
| Sep 30, 2023 | 836,000.00 |
| Sep 30, 2023 | 836,000.00 |